Contact us

PACTT congratulates CHUV MassChallenge laureates HaYa and Lymphatica

We are proud to announce that HaYa and Lymphatica, two start-up projects from the University Hospital of Lausanne (CHUV), are amongst the gold winners of the MassChallenge Switzerland. HaYa Therapeutics is developing a first-in-class biopharmaceutical therapy to treat heart failure. The project is the result of a strong and dynamic collaboration between Thierry Pedrazzini (right), […]

We are proud to announce that HaYa and Lymphatica, two start-up projects from the University Hospital of Lausanne (CHUV), are amongst the gold winners of the MassChallenge Switzerland.

HaYa Therapeutics is developing a first-in-class biopharmaceutical therapy to treat heart failure. The project is the result of a strong and dynamic collaboration between Thierry Pedrazzini (right), Samir Ounzain (center) and Daniel Blessing (left).

Lymphatica Medtech SA, founded by Marco Pisano (right) and Valentina Triacca (center), is developing a micropump-based medical device for treatment of lymphedema, a chronic, disabling side effect of anti-cancer therapies. Marco Pisano was supported by the spring 2016 InnoTREK grant.

PACTT wishes full success to both teams!

Useful links :

Masschallenge website

Le Temps press release

Lymphatica website

Table of Contents

Interested in this project? Let’s Talk

Get in touch to discuss licensing opportunities, collaborative research, or technical specifications.

Contact Us

Other news & events

All news
Uncategorized
InnoTREK: one-year financial support to create your start-up

You are a UNIL-CHUV researcher who would like to create a start-up and need a financial support to start? Apply for a one-year InnoTREK grant of CHF 100’000.- to launch your project! Applications for the InnoTREK grant can be submitted throughout the year to the Knowledge Transfer UNIL CHUV. Project selection will take place in […]

Uncategorized
BioInnovation Day 2026 : Journée dédiée aux Innovateurs & Investisseurs

  Le BIND BioInnovation Day 2026 aura lieu le 1er avril 2026 au CHUV – Auditoire César Roux. Une trentaine de projets innovants issus des meilleures institutions académiques et de recherche de Suisse occidentale y seront présentés devant le public et les investisseurs. L’événement est organisé par BioAlps en partenariat avec KT UNIL–CHUV et UNITEC. […]

Uncategorized
A Unil Discovery for Vaccine Development Turns into a Start-Up

The CRISPRi-seq technology, stemming from fundamental research within the team of Professor Jan-Willem Veening at the University of Lausanne, has reached a decisive milestone: it has been licensed to the start-up “i-Seq Biotechnology”. This innovation paves the way for new vaccines against diseases for which there is currently no protection. It all started with a […]

What is your situation ?

Our team is available to discuss your needs, for free.

For Researcher

A personalized service to inventors
In collaboration with a professional network, with regards to all aspects of technology evaluation, protection of intellectual property rights and creation of a start-up.
Learn more

For Industry

Find a collaboration, or invest in a technology
We are the primary contact point to engage in any collaboration, partnership or venture with researchers from the University of Lausanne or the CHUV.
Learn more